← Back to Clinical Trials
Recruiting NCT06486233

NCT06486233 Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute Coronary Syndrome.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06486233
Status Recruiting
Phase
Sponsor Gia Dinh People Hospital
Condition Myocardial Infarction
Study Type OBSERVATIONAL
Enrollment 385 participants
Start Date 2024-02-22
Primary Completion 2026-03-01

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 385 participants in total. It began in 2024-02-22 with a primary completion date of 2026-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this is observational study is to compare about MACE events and predisposing factors related to MACE events in elderly patients with high-risk non-ST acute coronary syndromes receiving early versus late invasive treatment . This study will anwser two questions. Question 1: What will factors associate with implementing a late invasive strategy in elderly patients with high-risk non-ST-segment elevation acute coronary syndrome ? Question 2: Is a meaningful difference about mortality and complication rates as re-myocardial infarction, heart failure, re-hospitalization, stroke after 12 months between two groups of patients undergoing early invasive and late invasive strategies in elderly patients with in high-risk non-ST-segment elevation acute coronary syndrome?

Eligibility Criteria

Inclusion Criteria: * aged 60 years and older * high - risk non-ST-segment elevation acute coronary syndrome (according to the 2023 European Heart Association recommended standards). * receives reperfusion intervention. Exclusion Criteria: * Acute coronary syndrome due to stent thrombosis, or coronary artery bypass graft occlusion. * Incomplete medical records.

Contact & Investigator

Central Contact

Sang Thanh Nguyen, Doctor

✉ drsangthanhnguyen@gmail.com

📞 +84902489252

Frequently Asked Questions

Who can join the NCT06486233 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06486233 currently recruiting?

Yes, NCT06486233 is actively recruiting participants. Contact the research team at drsangthanhnguyen@gmail.com for enrollment information.

Where is the NCT06486233 trial being conducted?

This trial is being conducted at Ho Chi Minh City, Vietnam.

Who is sponsoring the NCT06486233 clinical trial?

NCT06486233 is sponsored by Gia Dinh People Hospital. The trial plans to enroll 385 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology